Sunday, February 17, 2019
Tags Bristol-Myers Squibb

Tag: Bristol-Myers Squibb

Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

Roche’s Tecentriq, Trailing Rival Drugs, Lifts Lung Cancer Survival

By John Miller ZURICH (Reuters)  A drug cocktail with Roche's Tecentriq added two months to small-cell lung cancer patients' lives, according to a study, aiding the...
Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

Study Preserves Hopes for Roche’s Tecentriq in Lung Cancer

By John Miller ZURICH (Reuters)  Swiss drugmaker Roche's hopes of having the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form...
Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage

Mixed Results for Bristol/Nektar Combination in Cancer Trial

Chicago (Reuters) Mixed results over the weekend from closely watched studies combining Bristol-Myers Squibb Co's cancer immunotherapy with Nektar Therapeutics experimental drug NKTR-214, led...
Bottles of medications line the shelves at a pharmacy in Portsmouth

Roche Drugs Show Limited Benefit in Lung, Breast Cancer Trials

By Deena Beasley CHICAGO (Reuters)  In a disappointment for Roche Holding AG, two of its oncology drugs provided only modest protection from disease progression in lung...
The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, Switzerland.

Roche’s Tecentriq Cocktail Adds to Lung Cancer Survival Success

ZURICH (Reuters) Roche's Tecentriq immunotherapy combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss company said as it seeks...
Swiss drugmaker Roche's logo is seen at their headquarters in Basel

Roche’s Tecentriq Notches Third Cancer Cocktail Trial Win

By John Miller ZURICH (Reuters) Roche's immunotherapy Tecentriq on Tuesday racked up a third trial win in combination with other cancer drugs, a boost for...